Extended linifanib therapy in patients with advanced solid tumors in a phase I trial.

被引：1
|
作者：
Goh, B. C.
Wong, C.
Qian, J.
McKeegan, E.
Ricker, J. L.
Carlson, D. M.
Soo, R. A.
机构：
[1] Natl Univ Hlth Syst, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Singapore 117548, Singapore
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.3053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3053
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors
    Ryan, David P.
    Appleman, Leonard J.
    Lynch, Thomas
    Supko, Jeffrey G.
    Fidias, Panagiotis
    Clark, Jeffrey W.
    Fishman, Mayer
    Zhu, Andrew X.
    Enzinger, Peter C.
    Kashala, Oscar
    Cusack, James, Jr.
    Eder, Joseph P.
    CANCER, 2006, 107 (10) : 2482 - 2489
  • [42] Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors
    Duran, I
    Siu, LL
    Chen, EX
    Oza, AM
    Sturgeon, J
    Chin, SF
    Brown, S
    Pond, GR
    Nottage, M
    ANTI-CANCER DRUGS, 2006, 17 (01) : 81 - 87
  • [43] Lefitolimod (TLR agonist) and ipilimumab in patients with advanced solid tumors: A phase I trial
    Nardo, Mirella
    Reilley, Matthew
    Biter, Amadeo
    Lim, Joann
    Bean, Stacie A.
    Nguyen, Ly Minh
    Bhosale, Priya
    Ager, Casey
    Couillault, Coline A.
    Piha-Paul, Sarina A.
    Fu, Siqing
    Tsimberidou, Apostolia Maria
    Yap, Timothy A.
    Naing, Aung
    Ahnert, Jordi Rodon
    Subbiah, Vivek
    Karp, Daniel D.
    Curran, Michael A.
    Hong, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [45] Ipilimumab: First results of a phase I trial in pediatric patients with advanced solid tumors
    Merchant, Melinda S.
    Baird, Kristin
    Wexler, Leonard H.
    Rodriguez-Galindo, Carlos
    Mackall, Crystal
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Phase I trial of coramsine (SBP002) in patients with advanced solid tumors
    Millward, M
    Powell, A
    Tyson, S
    Daly, P
    Ferguson, R
    Carter, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 218S - 218S
  • [47] A clinical phase I trial of topotecan in combination with carboplatin in patients with advanced solid tumors
    Thodtmann, R
    Kemmerich, M
    Depenbrock, H
    Heuser, A
    van Oosterom, AT
    Hanauske, AR
    ANNALS OF ONCOLOGY, 1998, 9 : 69 - 69
  • [48] Linifanib phase II trial in patients with advanced hapatocallular carcinoma (HCC)
    Toh, H.
    Chen, P.
    Carr, B. I.
    Knox, J. J.
    Gill, S.
    Qian, J.
    Qin, Q.
    Ricker, J. L.
    Carlson, D. M.
    Yong, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Phase II trial of linifanib in patients (pts) with advanced renal cell carcinoma (RCC): Analysis of pts receiving extended therapy.
    Posadas, E. M.
    Tannir, N. M.
    Wong, Y.
    Ernstoff, M. S.
    Kollmannsberger, C. K.
    Qian, J.
    Ansell, P. J.
    McKeegan, E. M.
    Mckee, M. D.
    Ricker, J. L.
    Carlson, D. M.
    Michaelson, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy
    Michael J. Pishvaian
    Rebecca Slack
    Eunice Y. Koh
    Jan H. Beumer
    Marion L. Hartley
    Ion Cotarla
    John Deeken
    Aiwu Ruth He
    Jimmy Hwang
    Shakun Malik
    Kashif Firozvi
    Minetta Liu
    Beth Elston
    Sandy Strychor
    Merrill J. Egorin
    John L. Marshall
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 843 - 853
12345